Answers are grounded in this paper and cite their sources.
Key Points DCA, an inhibitor of PDKs, impedes glucose uptake and aerobic glycolysis in activated platelets. DCA inhibits agonist-induced human and mouse platelet aggregation and arterial thrombosis without altering hemostasis in mice.
No takes yet. Share an insight, caveat, or question.
Nayak et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: